PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer
Abstract High-grade serous ovarian cancers (HGSOC) represent the most common subtype of ovarian malignancies. Due to the frequency of late-stage diagnosis and high rates of recurrence following standard of care treatments, novel therapies are needed to promote durable responses. We investigated the...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/43b3a91fdd2f4465a835393a7f3b1b6b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|